Strength 88, price tag 35 — the quiet day I picked up Samsung Biologics
Today I picked up Samsung Biologics. The macro regime read neutral, the kind of day when the market commits to nothing, so my basket quietly ended with this one name. It's a B grade, 55.5 overall.
An 88-point body with a 35-point price tag
| Item | Score |
|---|---|
| Fundamentals | 88 |
| Catalyst | 66 |
| Risk | 38 |
| Valuation | 35 |
| Technicals | 35 |
| Overall | 55.5 (B) |
The 88 on fundamentals says the business itself is very strong, while 35 on valuation and 35 on technicals say the price isn't cheap and the chart isn't backing it up yet. So 55.5 and a B is less conviction and more a small bet on the body of the company. Risk at 38 is on the low side and the catalyst at 66 is decent, which was enough to keep me interested.
Shinhan Financial stays on the watchlist only, and SK Telecom stays under observation. Today's numbers gave me no reason to put either in the basket. The yardstick I used on Samsung Biologics is what I'll reapply: once valuation and technicals climb out of the 35s, they go back on the scale.
My existing holdings stay as they are, no selling, no adding. On a neutral day I'd rather move my hands less. The portfolio grew by one slot, and I haven't forgotten that this slot is a B.